Category: Volcano Corp.
Here's a look at some of the top legal news stories for medical device companies this week.
Volcano agrees that St. Jude Medical isn't infringing a pair of its fractional flow reserve patents after a court ruling doesn't go its way, but vows to appeal.
Officials at Volcano discuss the company's Q4 2013 earnings. The company reported losses of $20.5 million, or 38¢ per share, on sales of $103.3 million for the 3 months ended December 31, for swing to losses on sales growth of 0.8%.
California medtech company Volcano closes out its fiscal 2013 with steep losses, and a challenging outlook on Japanese revenues for the year to come.
San Diego-based Volcano (NSDQ:VOLC) dropped 4 points on Wall Street today after the company unveiled more red ink for its 4th quarter of 2013.
Volcano Corp. lowers its outlook for 2014, sending share prices down on Wall Street this morning.
Volcano (NSDQ:VOLC) lowered its outlook for 2014 this morning, sending share prices down on Wall Street despite positive preliminary results for the 4th quarter.
Shares of Volcano Corp. are up this morning after the medical device company launches a stock buyback worth up to $200 million.
A stock buyback worth up to $200 million sent shares of Volcano (NSDQ:VOLC) up nearly 6% this morning.
Analyst say that diagnostics maker Volcano is looking more and more like an attractive target for the likes of Medtronic or Abbott Labs.
MASSDEVICE ON CALL — Diagnostics and stents maker Volcano (NSDQ:VOLC) may be primed for acquisition, with a raft of analysts' groups debating only the timing of a buy.